Safety and Efficacy in Relapsed or Refractory Classic Hodgkin's Lymphoma Treated with PD-1 Inhibitors: A Meta-Analysis of 9 Prospective Clinical Trials

BACKGROUND: Classic Hodgkin's lymphoma (cHL) is characterized by the unique biology in which rare Hodgkin-Reed-Sternberg cells propagate an immunosuppressive microenvironment. Checkpoint inhibitors that target the interaction of PD-1 immune checkpoint receptors have demonstrated remarkable acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xueyan, Chen, Li, Zhao, Yawei, Yin, Huiru, Ma, He, He, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948280/
https://www.ncbi.nlm.nih.gov/pubmed/31950058
http://dx.doi.org/10.1155/2019/9283860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948280/
https://www.ncbi.nlm.nih.gov/pubmed/31950058
http://dx.doi.org/10.1155/2019/9283860

Ejemplares similares